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ABSTRACT: The design of an enantioselective Pd(II)-catalyzed C–
H amination reaction enabled by a comprehensive understanding of 
the reaction mechanism is described. The use of a chiral BINOL phos-
phoric acid ligand enables the conversion of readily available amines 
into synthetically valuable aziridines in high enantiomeric ratios. The 
aziridines can be derivatized to afford a range of chiral amine building 
blocks incorporating motifs readily encountered in pharmaceutically 
relevant molecules. 
The development of catalytic enantioselective aliphatic C–H bond 
functionalization processes represents an important challenge for 
chemical synthesis.1 Most prominent among the successful advances 
towards this ideal has been the use of metallo-carbenoid and –
nitrenoid strategies.2 In contrast, processes that are based on enantiose-
lective metal insertion into aliphatic C–H bonds remain limited.3 Part 
of the reason for this deficiency is the lack of available chiral ligands 
that are effective for oxidative C–H functionalization with catalysts 
derived from palladium(II) salts. The most common classes of ligand 
for metal-catalyzed enantioselective reactions, chiral phosphines,3 are 
generally incompatible with the reactions conditions required for oxi-
dative Pd-catalyzed C–H bond functionalization. As a result, the design 
of novel classes of ligands for Pd(II) catalysts has been the focus of 
significant attention in the synthetic community (Figure 1a).4 
The catalytic enantioselective desymmetrization of prochiral me-
thyl groups via Pd-catalyzed Csp3–H activation represents a potentially 
useful strategy for the generation of compounds displaying non-
racemic fully substituted carbon atoms. To date, however, successful 
examples of this ideal remain limited. Enantioselective desymmetriza-
tion of prochiral methyl groups has been successfully achieved using 
Pd(0)-catalyzed methods; Kagan, Baudoin, Kundig and Cramer have 
all reported variations on a C–H amination to indolines.3 Less common 
are successful examples of enantioselective oxidative C–H desymme-
trization using Pd(II)-catalysts. For example, Yu and co-workers have 
reported a Pd(II)-mediated, chiral auxiliary-controlled disatereoselec-
tive C–H iodination of oxazolines,4a and Pd(II)-catalyzed C–H func-
tionalizations controlled by amino acid-based ligands that give moder-
ate but promising levels of enantioselectivity for alkylation and aryla-
tion reactions.4b,c Related to this, our own efforts identified that similar 
amino-acid derived ligands enable Pd(II)-catalyzed enantioselective 
arylation of tetramethyl-piperidine with moderate enantioselectivity.5c  
Our laboratory has been engaged in the development a series of 
processes for the Pd-catalyzed C–H functionalization of free(NH) 
aliphatic amines.5 Central to the success of many of these reactions has 
been the presence of a putative hydrogen bond between the NH motif 
of a ligated amine and the carbonyl oxygen atom of the Pd-bound car-
boxylate.5b For example, in the case of tetramethylmorpholinone 1a, a 
hydrogen bond helps to arrange the C–H bond into the ideal orienta-
tion for C–H activation with a second Pd-bound carboxylate (int-I, 
Figure 1b). Based on this, we reasoned that deployment of a chiral 
carboxylate or related anionic ligand might lead to a scenario wherein 
the irreversible C–H bond cleavage step would be rendered enantiose-
lective via the desymmetrization of two prochiral methyl groups, lead-
ing ultimately to non-racemic aliphatic amine products. 
 
Figure 1. A strategy towards anionic ligand-controlled enantioselec-
tive Pd-catalyzed C–H activation 
The use of chiral anionic ligands to control enantioselective C–H 
activation with palladium catalysts has only recently received attention. 
Aside from the deployment of chiral amino acid derivatives as biden-
tate ligands,4 Duan et al have described the use of BINOL-derived 
phosphoric acids6,7 to impart modest enantioselective in a methylene 
C–H arylation reaction.8  Based on this seminal discovery, two further 
reports detailing chiral BINOL-phosphates as effective ligands for 
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 enantioselective C–H activation recently emerged; Yu and co-workers 
detailed a highly selective enantiotopic methylene C–H arylation in 
thioamide derivatives9a and Chen et al reported an auxiliary-directed 
C–H arylation of amide derivatives.9b Here, we report our own studies 
on the use of a BINOL-phosphoric acid derivative,6 as a chiral anionic 
ligand,7 to enable the Pd-catalyzed enantioselective C–H amination of 
aliphatic amines to form aziridines.  High enantioselectivities and yields 
are obtained for the aziridination process and the products of the reac-
tion can be readily transformed into novel variants of privileged satu-
rated amine hetereocycles, which we believe will be of significant inter-
est to practitioners of medicinal chemistry (Figure 1c). 
At the outset of our studies, we tested the enantioselective C–H 
amination of morpholinone 1a, to give aziridine 2a, by screening a 
range of chiral acids in combination with 5 mol% Pd(OAc)2 and phe-
nyliodosyldiacetate (PIDA) in toluene at 70 ˚C (see supporting infor-
mation for details). Unfortunately, none of these reactions resulted in 
significant enantioselectivity in the product. However, we did find that 
when 5 mol% of BINOL-derived phosphoric acid (BPA, 3a) was added 
to the reaction, a 16% yield and a low enantiomeric ratio (e.r.) of 53:47 
was observed (Table 1, entry 1). Based on this, we tested the 3,3’-
diaryl-BINOL phosphoric acid, (R)-TRIP 3b, under the same condi-
tions and found that although the e.r. had risen slightly to 55:45, the 
yield (by GC) was improved to 70% (entry 2). A screen of solvents 
revealed that reaction in EtOAc or 1,4-dioxane increased the e.r. of the 
products to 79:21 and 86.5:23.5 respectively, and with moderate yields 
(entries 4,5); notably, the reaction in dioxane did not reach comple-
tion. The addition of 2 equivalents of Ac2O did not significantly affect 
the reaction (entry 9). We also found that the addition of 20 equiva-
lents of AcOH, found to be beneficial in the racemic reaction,5b re-
duced the reaction to an almost racemic process, albeit in high yield 
(entry 10). Reducing the concentration to 0.05 M increased the yield 
of the product to 71% and the e.r. to 84:16 (entry 11). We next in-
creased the amount of (R)-TRIP in the reaction to maximize the for-
mation of the chiral-palladium catalyst, thereby minimizing any non-
chiral background reaction involving Pd(OAc)2; using 10 mol% of (R)-
TRIP with 5 mol% Pd(OAc)2 gave an e.r. of 89:11 with 67% yield of 2a 
(entry 12). Increasing the loading of Pd(OAc)2 to 10 mol%, combined 
with 20 mol% of (R)-TRIP and the addition of 0.5 equivalents of Ac2O 
gave 79% yield of the product with an e.r. of 93.5:6.5 (entry 13, Condi-
tion A). To the best of our knowledge, this represents the first example 
of a highly enantioselective Pd(II)/Pd(IV)-catalyzed process for 
desymmetrizing C–H functionalization of prochiral methyl groups. 
We were conscious that using PIDA as oxidant generates two 
equivalents of AcOH, whose increasing concentration throughout the 
reaction may compromise the enantioselectivity of the process (entry 
10). Accordingly, we found that use of ‘acetate-free’ oxidants such as 
iodosylbenzene or iodine,4a,10 resulted in an improved enantiomeric 
ratio of 86:14 and 95:5 respectively, but the yields were dramatically 
reduced (entries 14,15).11 Multiple oxidants were investigated in order 
to attain catalytic turnover and it was found that addition of AgOAc 
improved the yield and maintained the e.r. of the product (entry 16). 
After further optimization of the reaction parameters (lowering con-
centration, increasing catalyst loading and increasing temperature) we 
found that 88% yield of aziridine product with an e.r. of 96.5:3.5 could 
be obtained (entry 17, Condition B). It is clear that the enantioselectiv-
ity depends on a delicate balance between the concentration of AcOH 
and the chiral TRIP ligand, suggesting that AcO– can replacing the 
TRIP ligand on the palladium(II) center at high concentrations of 
AcOH, leading to racemic turnovers. Therefore, it is possible that using 
20 mol% of the TRIP ligand offsets this problem, particularly towards 
the end of the reaction. Furthermore, by using AgOAc, which is heter-
ogeneous in this reaction, we suggest that its insolubility is beneficially 
modulating the concentration of AcO–/AcOH.12 Taken together, the 
optimization studies revealed two sets of reaction conditions (A and B) 
for a Pd-catalyzed enantioselective C–H amination to aziridines. 
With optimal conditions in hand, we explored the scope of the Pd-
catalyzed enantioselective C–H amination (Table 2). First, we assessed 
simple derivatives of the morpholinone scaffold and found that varia-
tions at both sides of the free(NH) amine were accommodated. In 
addition to the tetramethyl morpholinone 1a, a cyclohexyl-derived 
Table 1. Selected optimization data for enantioselective Pd-catalyzed C–H amination to aziridines 
 
entry Pd(OAc)2, mol% (R)-TRIP, 
mol% 
Solvent Oxidant Additives / 
comments 
Conc., M Yield (GC) e.r. (GC) 
1 5 5 (of 3a) PhMe PIDA – 0.1 16 53:47 
2 5 5 PhMe PIDA – 0.1 65 55:45 
3 5 5 1,2-DCE PIDA – 0.1 70 61:39 
4 5 5 EtOAc PIDA – 0.1 64 79:21 
5 5 5 1,4-dioxane PIDA – 0.1 44 86.5:23.5 
6 5 5 MeOAc PIDA – 0.1 64 80:20 
7 5 5 TBME PIDA – 0.1 4 80:20 
8 5 5 DMA PIDA – 0.1 32 57.5:42.5 
9 5 5 EtOAc PIDA 2 equiv. Ac2O 0.1 75 78.5:21.5 
10 5 5 EtOAc PIDA 20 equiv. AcOH 0.1 82 52:48 
11 5 5 EtOAc PIDA – 0.05 71 84:16 
12 5 10 EtOAc PIDA – 0.05 67 89:11 
13a 10 20 EtOAc PIDA 0.5 equiv. Ac2O 0.05 79 93.5:6.5 
14 5 5 EtOAc PhI=O – 0.1 10 86:14 
15 5 10 EtOAc I2 0.5 equiv. Ac2O  0.05 4 95:5 
16 5 10 EtOAc I2, AgOAc  0.05 86 95:5 
17b 10 20 EtOAc I2, AgOAc 90 ˚C 0.033 88 96.5:3.5 
aCondition A. bCondition B. 
O
N
Me
Me
H
O
O PO
O
OH
X
X
(R)-3a, (R)-BPA, X = H
(R)-3b, (R)-TRIP, X = 2,4,6-(i-Pr)3-C6H3
catalytic Pd(OAc)2
catalytic anionic ligand 3a or 3b
oxidant,solvent
70 ˚C, 7 h
amine, 1a aziridine, 2a Binol-phosphoric acids, 3
X
NO
Me
Me
Me
MeMe
 substrate worked effectively in the reaction giving a 95:5 enantiomeric 
ratio in the product aziridine 2b with moderate yield.  
Table 2. Scope of enantioselective C–H amination 
 
Conditions A: Substrate (1.0 equiv.), 10 mol% Pd(OAc)2, PhI(OAc)2 
(2.5–4.0 equiv.), Ac2O (0.5 equiv.), 20 mol% (R)-TRIP, EtOAc (0.05 
M). Conditions B: Substrate (1.0 equiv.), 10 mol% Pd(OAc)2, AgOAc 
(3.0 equiv.), I2 (2.0 equiv.), 20 mol% (R)-TRIP, EtOAc (0.033 M). 
Yields are quoted after flash column chromatography. Chiral analysis 
was carried out using GC or HPLC. 
We were pleased to observe that methylene C–H amination to the 
spirocyclic aziridine 2c product was also successful with an excellent 
e.r. of 94.7:5.3, the low yield being comparable to that of the racemic 
reaction. Aziridine 2c was also crystalline, enabling determination of its 
absolute configuration via X-ray diffraction. We also investigated the 
corresponding piperazinone scaffold, wherein the heterocyclic oxygen 
of the morpholinone is replaced by a nitrogen containing group; suc-
cessful C–H activation on these substrates would substantially broaden 
the scope of the reaction and provide access to more medicinally rele-
vant heterocyclic products. We were pleased to find that a series of 
functionalized N-alkyl derivatives containing benzyl, glycinyl, and 
hydroxylethyl motifs all worked well in the reaction, delivering the 
aziridine products (2d-f) in good yield and high e.r’s. N-Aryl substrates 
also worked well in the reaction and a range of electronic and steric 
properties were tolerated, with electron rich (2g-j), electron deficient 
(2k-m) and even Lewis basic heterocyclic motifs (2n) all providing the 
corresponding aziridines in good yields and high e.r’s. 
In considering the pathway through which this enantioselective 
transformation proceeds, it was important to rationalize the observa-
tion that a high concentration of acetate leads to a low enantioselectivi-
ty, while an acetate-free system results in a low yield of product. An 
explanation for this effect could involve an active Pd(II) complex dis-
playing one acetate and one TRIP ligand. It seems unlikely, based on 
the size of TRIP, that two of these ligands could be accommodated 
around the Pd(II) center; attempts to synthesize Pd(TRIP)2 were 
unsuccessful. We also noticed a variation in e.r. depending on the elec-
tronic properties of the N-aryl group in amines 2g-l. When the log(e.r.) 
of the aziridines is plotted against the Hammett s constant of the aryl 
substituent, one can draw a linear correlation between the enantiose-
lectivity and electronic properties of the group.13 Furthermore, it is 
noticeable that the e.r. in the corresponding morpholinones are higher 
than the lactam series, possibly reflecting the more electronegative 
nature of the lactone oxygen atom. 
Figure 2. Correlation between e.r. and Hammett constant 
 
Figure 3. Possible pathways for the enantioselective C–H activation 
 
We have previously shown that the Pd(II)-catalyst coordinates the 
free(NH) of the amine through the nitrogen lone pair in the pseudo-
axial position,5b which means that the subsequent C–H activation is 
only possible at the methyl group that is syn to the coordinated metal 
(pseudo-equatorial on the ring), leading to the four-membered ring 
cyclopalladation complex. As a result, one scenario could involve a 
hydrogen bond between the NH and the phosphate ligand, providing a 
rigid transition structure for C–H bond cleavage via a concerted-
metallation-deprotonation type pathway utilizing the acetate group 
(Figure 3a).14 A second possibility involves an acetate hydrogen bond-
ing to the ligated amine and the irreversible and enantiodetermining 
C–H bond cleavage mediated by the phosphate ligand (Figure 3b). 
While these models lay out a preliminary understanding of the factors 
that influence this reaction, it was not possible, at this stage, to further 
elucidate which pathway is prevalent, nor the nature of the excellent 
enantioselectivity observed in this reaction.15 Computational studies to 
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 elucidate the stereocontrolling elements of this catalyst-ligand combi-
nation are ongoing and will be reported in due course.  
We previously demonstrated that the aziridine ring in the morpho-
linone-derived products could be opened in the presence of nucleo-
philes. To test whether the corresponding lactam-aziridines were also 
compatible with this ring opening transformation, we subjected 2d to 
treatment with pyrazole in the presence of p-toluenesulfonic acid to 
reveal the amide product in 72% yield. Reduction of the lactam was 
achieved using LiAH4 in THF to afford highly substituted piperazine 4 
in good yield. We also showed that after opening 2d with MeOH, a 
second diastereoselective C–H amination takes place to form aziridine 
5 in good yield. Aziridine ring opening with pyrazole and subsequent 
lactam reduction affords piperazine 6 in good yield. We believe that 
these non-racemic highly functionalized saturated amine heterocycles 
would be difficult to form by other methods and should be attractive 
building blocks in medicinal chemistry programs.16 
Scheme 1. Synthesis of complex amines 
  
In conclusion, we have developed a Pd-catalyzed enantioselective 
C–H amination to aziridines using anionic BINOL phosphate ligands. 
A range of amines, displaying prochiral methyl groups, undergo enan-
tioselective desymmeterizing C–H activation to produce highly substi-
tuted and functionalized products that can be transformed into non-
racemic saturated heterocyclic building blocks. While the precise na-
ture of the enantiocontrol imparted by the TRIP ligands remains un-
clear, we believe that this asymmetric C–H activation process will be of 
significant utility to practitioners of synthetic and medicinal chemistry. 
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enantio-enriched
highly substituted
saturated amine
heterocycles
N
N
Me
Me
Me
N
N
H
Ph
N
NO
Me
Me
Me
Ph
(i) pyrazole, p-TsOH (72%)
(ii) LiAlH4, THF (83%)
2d
N
NO
Me
Me
OMe
Ph
(i) pyrazole, p-TsOH (78%)
(ii) LiAlH4, THF (61%)
(iii) MeOH, p-TsOH (66%)
(iv) 5 mol% Pd(OAc)2, PIDA
     AcOH, Ac2O, EtOAc (69%)
     [iterative C–H aziridination]
N
N
Me
Me
MeO
N
N
Ph
H
5
4
6
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X
N
Me
Me
H
O
RR
X
NO
R
R
Me
O PO
O
OH
Ar
Ar
10 mol% Pd(OAc)2
20 mol% (R)-TRIP
oxidant
(R)-TRIP14 examples, e.r. up to 97:3
